United Health Products, Inc. financial data

Symbol
UEEC on OTC
Location
Mesquite, NV
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4% % -12%
Quick Ratio 0.42% % -74%
Debt-to-equity -105% % 5.2%
Return On Equity 100% % 15%
Return On Assets -2142% % -155%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 258,690,253 shares 3.4%
Common Stock, Shares, Outstanding 258,690,253 shares 3.6%
Entity Public Float $40,229,446 USD -50%
Common Stock, Value, Issued $258,690 USD 3.6%
Weighted Average Number of Shares Outstanding, Diluted 257,809,759 shares 3.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Research and Development Expense $331,348 USD -17%
Operating Income (Loss) $2,776,149 USD -66%
Net Income (Loss) Attributable to Parent $2,946,552 USD -78%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Inventory, Net $0 USD -100%
Assets, Current $43,129 USD -32%
Operating Lease, Right-of-Use Asset $23,021 USD -58%
Assets $94,313 USD -37%
Accrued Liabilities, Current $325,437 USD 87%
Liabilities, Current $2,006,356 USD -10%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $3,433,856 USD 52%
Retained Earnings (Accumulated Deficit) $80,833,383 USD -3.8%
Stockholders' Equity Attributable to Parent $3,339,543 USD -58%
Liabilities and Equity $94,313 USD -37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $273,969 USD 32%
Net Cash Provided by (Used in) Financing Activities $110,000 USD -72%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 258,690,253 shares 3.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18,376 USD -58%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $5,348,000 USD 7%
Operating Lease, Liability $23,954 USD -57%
Lessee, Operating Lease, Liability, to be Paid $24,656 USD -59%
Operating Lease, Liability, Current $23,954 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Two $15,410 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $15,410 USD -58%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards $5,310,500 USD 6.4%
Additional Paid in Capital $77,235,150 USD 2.3%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $30,684 USD 303%